Tandem Diabetes Care Trading Higher On FDA Clearance For Its Tandem Mobi Insulin Pump

Shares of Tandem Diabetes Care, Inc. (TNDM), an insulin delivery and diabetes technology company, are rising more than 7% Tuesday morning after the company said it received clearance from the FDA for its Tandem Mobi insulin pump for people aged 6 and more.

The Tandem Mobi, which can be fully controlled from a mobile app, is the world’s smallest durable automated insulin delivery system, the company said.

TNDM is at $26.78 currently. It has traded in the range of $23.60 – $70.81 in the last 1 year.

Source: Read Full Article